Document Type


Publication Date



This article is the author’s final published version in Medicine, Volume 103, Issue 26, June 2024, Article number e38692.

The published version is available at Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.


BACKGROUND: Neutrophil to lymphocyte ratio (NLR) has been considered a prognostic biomarker of mortality and other major cardiac events. This study investigates NLR's efficacy in predicting in-hospital and long-term outcomes in patients with ST-segment elevated myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI).

METHODS: Electronic databases (PUBMED, Cochrane CENTRAL, ERIC, Embase, Ovid, and Google Scholar) were searched till June 2022 to identify studies having STEMI patients who underwent PCI. Risk ratios and mean differences (MDs), along with their corresponding 95% confidence intervals (Cis) and standard deviations (SDs), were pooled using a random-effect model. This meta-analysis has been registered on Prospero (ID: CRD42022344072).

RESULTS: A total of 35 studies with 28,756 patients were included. Pooled estimates revealed an increased incidence of primary outcomes; in-hospital all-cause mortality (RR = 3.52; 95% CI = 2.93-4.24), long-term all-cause mortality (HR = 1.07; 95% CI = 1.00-1.14), (RR = 3.32; 95% CI = 2.57-4.30); in-hospital cardiovascular mortality (RR = 2.66; 95% CI = 2.04-3.48), long-term cardiovascular mortality (RR = 6.67; 95% CI = 4.06-10.95); in-hospital major adverse cardiovascular events (MACE) (RR = 1.31; 95% CI = 1.17-1.46), long-term MACE (RR = 2.92; 95% CI = 2.16-3.94); length of hospital stay (WMD = 0.60 days; 95% CI = 0.40-0.79) in patients with high NLR compared to those with a low NLR.

CONCLUSION: NLR might be a valuable tool for prognostication (in-hospital) and stratification of patients with STEMI who underwent PCI.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License

md_2024_06_06_swed_md-d-22-07990_sdc1.docx (31 kB)
Supplemental Digital Content 1

md_2024_06_06_swed_md-d-22-07990_sdc2.docx (14 kB)
Supplemental Digital Content 2

md_2024_06_06_swed_md-d-22-07990_sdc3.docx (29 kB)
Supplemental Digital Content 3

md_2024_06_06_swed_md-d-22-07990_sdc4.docx (12 kB)
Supplemental Digital Content 4

md_2024_06_06_swed_md-d-22-07990_sdc5.docx (18 kB)
Supplemental Digital Content 5

md_2024_06_07_swed_md-d-22-07990_sdc6.docx (12 kB)
Supplemental Digital Content 6

PubMed ID




Included in

Cardiology Commons